“Venlafaxine Hydrochloride Controlled Release Bilayer Tablets: Optimization of Formulation Variable by Using Dyspnea on Exertion”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 2, pp. 141–147, Mar. 2020, doi: 10.25004/IJPSDR.2020.120208.